Matthew R. Redinbo

University of North Carolina at Chapel Hill — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

68h-index17.6kcitations359works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gut microbiota and health(74), Pharmacogenetics and Drug Metabolism(40), Cancer therapeutics and mechanisms(34), Probiotics and Fermented Foods(28), Estrogen and related hormone effects(28)

Publications359 total

Commercially purchased and in-house bred C57BL/6 mice with different gut microbiota exhibit distinct indomethacin-induced toxicities
Gut Microbes Reports·2025Open Access
Discovery of CHD1 Antagonists for PTEN-Deficient Prostate Cancer
UNC Libraries·2025Open Access
Sex-dependent responses in mice to indomethacin-induced organ injury and gut microbiome-targeted alleviation
UNC Libraries·2025Open Access
Sex-dependent responses in mice to indomethacin-induced organ injury and gut microbiome-targeted alleviation
Scientific Reports·2025· 1 citedOpen Access
Gut Microbiome Meta-Transcriptomics Associated with Mycophenolate Mofetil Enterohepatic Recirculation in Kidney Transplant Recipients
American Journal of Transplantation·2025
Microbiota and kidney disease: the road ahead
Nature Reviews Nephrology·2025· 11 citedOpen Access
Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study
UNC Libraries·2025Open Access
Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study
BMC Cancer·2025Open Access
Structural Insights into Selectively Targeting <i>Candida albicans</i> Hsp90
Biochemistry·2025· 1 cited
Author response for "Emerging Gut Microbial Glycoside Hydrolase Inhibitors"
2025
Commercially Purchased and In-House Bred C57BL/6 Mice with Different Gut Microbiota Exhibit Distinct Indomethacin-Induced Toxicities
2025Open Access
Sex-Dependent Responses in Mice to Indomethacin-Induced Injury and Gut Microbiome-Targeted Alleviation
2025Open Access
Glucuronidation Metabolomic Fingerprinting to Map Host-Microbe Metabolism
2025Open Access
Diverse MarR bacterial regulators of auxin catabolism in the plant microbiome
UNC Libraries·2025Open Access
Emerging gut microbial glycoside hydrolase inhibitors
RSC Chemical Biology·2025· 1 citedOpen Access
The role of gut microbial β-glucuronidases in carcinogenesis and cancer treatment: a scoping review
UNC Libraries·2024Open Access
The role of gut microbial β-glucuronidases in carcinogenesis and cancer treatment: a scoping review
Journal of Cancer Research and Clinical Oncology·2024· 9 citedOpen Access
Discovery of CHD1 Antagonists for PTEN-Deficient Prostate Cancer
Journal of Medicinal Chemistry·2024· 5 citedOpen Access
In vitro and in vivo studies on the metabolism and pharmacokinetics of the selective gut microbial β-glucuronidase targeting compound Inh 1
UNC Libraries·2024· 1 citedOpen Access
Advanced piperazine-containing inhibitors target microbial β-glucuronidases linked to gut toxicity
UNC Libraries·2024Open Access
page 1 of 18Next →

Frequent Co-authors

Sridhar Mani(9), Philip M. Potter(8), Sompop Bencharit(7), Bret D. Wallace(5), Christopher L. Morton(5), Jillian Orans(4), Linda B. Moore(4), Jon L. Collins(4), Steven A. Kliewer(4), William G. Walton(4), Samuel J. Pellock(4), Madhukumar Venkatesh(3), Lance Stewart(3), James J. Champoux(3), Wim G. J. Hol(3), Ryan E. Watkins(3), G. Bruce Wisely(3), Timothy M. Willson(3), Aadra P. Bhatt(3), Eric A. Ortlund(3)